摘要
目的评价三仁汤合小蓟饮子治疗慢性肾炎血尿的临床疗效与安全性。方法将60例符合标准的患者用随机分组法分为治疗组和对照组。所有受试者在试验期间,其慢性肾炎基础治疗不变。治疗组:三仁汤合小蓟饮子100 m L/次,每天3次,4周为1个疗程。对照组:慢性肾炎基础治疗。以中医证候疗效作为疗效评价指标,并观察尿红细胞计数、血肌酐的变化。共纳入60例患者,全部按方案完成观察。结果治疗组总有效率为86.7%;对照组总有效率为20%,2组疗效比较差异有统计学意义(P<0.01)。2组治疗后尿红细胞计数比较有统计学意义,2组血肌酐无统计学差异,治疗组疗效优于对照组。结论三仁汤合小蓟饮子具有较好的临床疗效和安全性。
Objective: To evaluate the clinical effect and the safety of San Ren Decoction combined Xiaoji Drink on the treatment of chronic nephritis hematuria patients. Methods: 60 patients were randomly divided into a treatment group and a control group. All subjects during the test kept their chronic nephritis basic treatment unchanged. The treatment group was given San Ren Decoction combined Xiaoji Drink 100mL/once, 3 times a day, four weeks a course of treatment. The control group simply kept the chronic nephritis basic treatment. By taking TCM syndromes as effectiveness evaluation, red blood cell count and serum creatinine change were observed. Results: The total effective rate of the treatment group was 86.7% while that of the control group was 20%. The comparative difference of the two groups was statistically significant (P 〈 0. 01 ). The comparison of the urinary red blood cell count of the two groups was statistically significant, but the comparison of serum creatinine of the two groups had no significant difference. The clinical effectiveness of the treatment group was batter than that of the control group. Conclusion: San Ren Decoction combined Xiaoji Drink has a better clinical effect and safety.
出处
《云南中医中药杂志》
2015年第11期37-38,共2页
Yunnan Journal of Traditional Chinese Medicine and Materia Medica
关键词
三仁汤
小蓟饮子
慢性肾
小球肾炎
血尿
San Ren Decotion, Xiaoji Drink, chronic glomerulonephritis, hematuria